Blueprint
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM SD
Specialized Disclosure Report
Atrion Corporation
(Exact name of registrant as specified in its charter)
|
Delaware
|
|
0-10763
|
|
63-0821819
|
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
|
One Allentown Parkway,
Allen, Texas
|
|
75002
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
Jeffery Strickland
|
|
|
(972) 390 -9800
|
|
(Name and telephone number, including area code, of the person to
contact in connection with this report.)
|
Check
the appropriate box to indicate the rule pursuant to which this
form is being filed, and provide the period to which the
information in this form applies:
|
x
|
Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for
the reporting period from January 1 to December 31,
2017.
|
Company Profile: Atrion Corporation and its subsidiaries
(”we,” “our,” “us,”
“Atrion,” or the “Company”) develop and
manufacture products, primarily for medical applications. Our
medical products range from fluid delivery devices to ophthalmic
and cardiovascular products.
Section 1 – Conflict Minerals Disclosure
Item 1.01 Conflict Minerals Disclosure and Report
In
accordance with the disclosure requirements promulgated by the U.S.
Securities and Exchange Commission (“SEC”), we have
undertaken efforts to determine our conflict minerals1 reporting requirements for the period
from January 1 to December 31, 2017.
We have
determined that during 2017 our company manufactured (or contracted
to manufacture) products as to which conflict minerals are
necessary to the functionality or production of such products. As
is required, we have conducted a good faith reasonable country of
origin inquiry (“RCOI”) to determine whether the
necessary conflict minerals originated in the Democratic Republic
of the Congo (“DRC”) or an adjoining country
(collectively the “Covered Countries”) or came from
recycled or scrap sources.
Atrion’s RCOI process included conducting an inquiry of our
direct suppliers using the Responsible Minerals Initiative’s
Conflict Minerals Reporting Template (“CMRT”). We
relied upon our suppliers’ representations regarding the
origin of their minerals and their smelter data to determine the
source of the conflict minerals within our supply chain. Based on
the results of our RCOI, we exercised due diligence on the source
and chain of custody of the conflict minerals.
The
Company has filed this Specialized Disclosure Form (“Form
SD”) and the associated Conflict Minerals Report, which
appears as Exhibit 1.01 hereto and is publicly available at
http://atrioncorp.com/investor_relations/Investor_Relations.htm.
Item 1.02 Exhibit
A copy
of the Company’s Conflict Minerals Report is provided as
Exhibit 1.01 hereto.
Section 2 – Exhibits
Item 2.01 Exhibits
The
following exhibit is filed as part of this report:
Exhibit
1.01 – Atrion Corporation’s Conflict Minerals Report
for the period January 1 to December 31, 2017 as required by Items
1.01 and 1.02 of this Form.
Signatures
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the duly authorized undersigned.
Atrion
Corporation
(Registrant)
By:
/s/ Jeffery
Strickland
Jeffery
Strickland
Vice
President and Chief
Financial
Officer
|
|